Avior Wealth Management LLC Has $761,000 Stake in Option Care Health, Inc. (NASDAQ:OPCH)

Avior Wealth Management LLC increased its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 11.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,300 shares of the company’s stock after purchasing an additional 2,442 shares during the quarter. Avior Wealth Management LLC’s holdings in Option Care Health were worth $761,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Harbor Capital Advisors Inc. boosted its stake in Option Care Health by 317.9% in the second quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company’s stock valued at $2,670,000 after acquiring an additional 73,312 shares during the last quarter. Comerica Bank boosted its stake in Option Care Health by 6.5% in the first quarter. Comerica Bank now owns 760,915 shares of the company’s stock valued at $25,521,000 after acquiring an additional 46,639 shares during the last quarter. Janus Henderson Group PLC boosted its stake in Option Care Health by 182.9% in the first quarter. Janus Henderson Group PLC now owns 227,135 shares of the company’s stock valued at $7,617,000 after acquiring an additional 146,837 shares during the last quarter. Victory Capital Management Inc. boosted its stake in Option Care Health by 4,432.8% in the third quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock valued at $50,756,000 after acquiring an additional 1,585,818 shares during the last quarter. Finally, Edgestream Partners L.P. boosted its stake in Option Care Health by 96.8% in the second quarter. Edgestream Partners L.P. now owns 351,476 shares of the company’s stock valued at $9,736,000 after acquiring an additional 172,845 shares during the last quarter. 98.05% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the stock. The Goldman Sachs Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. JMP Securities raised their price objective on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a report on Monday, September 30th. Truist Financial lowered their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Finally, Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $43.00 to $29.00 in a research report on Wednesday, October 30th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, Option Care Health presently has an average rating of “Moderate Buy” and a consensus target price of $30.83.

Option Care Health Trading Up 0.3 %

NASDAQ:OPCH opened at $21.88 on Thursday. The firm has a market cap of $3.72 billion, a P/E ratio of 18.39, a P/E/G ratio of 2.27 and a beta of 1.32. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $34.63. The firm’s fifty day moving average is $27.98 and its 200-day moving average is $29.21. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.

Insiders Place Their Bets

In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the stock in a transaction dated Friday, November 8th. The stock was bought at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the acquisition, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.